Efficacy of Russian immunologic skin test recombinant allergen Diaskintest - ten years (meta-analysis data)

A. Starshinova (St. Petersburg, Russian Federation), D. Kudliy (Moscow, Russian Federation), I. Dovgaluk (St. Petersburg, Russian Federation)

Source: Virtual Congress 2020 – Non-tuberculous mycobacteria and latent tuberculosis infection
Session: Non-tuberculous mycobacteria and latent tuberculosis infection
Session type: E-poster session
Number: 2813
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Starshinova (St. Petersburg, Russian Federation), D. Kudliy (Moscow, Russian Federation), I. Dovgaluk (St. Petersburg, Russian Federation). Efficacy of Russian immunologic skin test recombinant allergen Diaskintest - ten years (meta-analysis data). 2813

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
A PKPD mathematical model to determine efficacy of multiple doses of QGE031 (ligelizumab) vs. omalizumab and placebo in inhibiting skin responses in atopic asthmatics
Source: International Congress 2015 – Asthma mechanisms and management
Year: 2015


Screening for TB infection in children using skin tests with tuberculin and recombinant allergen (CFP-10-ESAT-6)
Source: Virtual Congress 2020 – Non-tuberculous mycobacteria and latent tuberculosis infection
Year: 2020


The impact of age and BCG-vaccination on TST and IGRA responses in children: data from over 1000 children in a European multicentre study (TBNET#17)
Source: Annual Congress 2013 –TBNET 2013: latest results
Year: 2013


Association with TB exposure of tuberculin skin test and interferon-γ release assays. A systematic review
Source: Annual Congress 2007 - Gamma-interferon-based tests to diagnose tuberculosis infection and disease
Year: 2007


Changes in skin prick test (SPT) from the age of 1 to 6 years (yrs) and relationship to specific IgE and atopic dermatitis: The French arm of PASTURE European study
Source: Annual Congress 2012 - Severe asthma and developing allergy in childhood
Year: 2012



Effectiveness of tuberculosis detection using a skin test with allergen recombinant (CFP-10-ESAT-6) in children
Source: International Congress 2015 – Biomarkers in TB: immunology and physiology
Year: 2015


Relation between circulating allergen specific IgE, skin prick test reactivity and wheeze. Results from phase two of the international study of asthma and allergy in childhood (ISAAC)
Source: Annual Congress 2008 - Asthma epidemiology
Year: 2008

Experience of skin test application using tuberculosis recombinant allergen (Diaskintest) in tuberculosis diagnostics of children
Source: International Congress 2015 – Biomarkers in TB: immunology and physiology
Year: 2015

Tuberculin skin test (TST) conversions rates, its relationship with interferon gamma release assay and safety and efficacy of 4 months rifampicin therapy (4R) for latent TB infection (LTBI) among nursing students in south India
Source: Annual Congress 2010 - Special treatment options in tuberculosis
Year: 2010


Safety of segmental allergen challenge in human allergic asthma
Source: Annual Congress 2007 - Novel aspects in airway inflammation in human asthma and rhinitis
Year: 2007



Evaluation of the immunogenicity and safety of a new formulation of omalizumab (solution for injection) in patients with allergic (IgE-mediated) asthma
Source: Annual Congress 2009 - Severe asthma and its treatment
Year: 2009


Effect of subcutaneous allergen immunotherapy on the natural course of allergic diseases: a retrospective cohort study
Source: International Congress 2019 – Asthma education: lifestyle and adolescence
Year: 2019

Long-term efficacy of omalizumab (OMA) for patients with severe allergic asthma (SAA). Clinical assessment and relationship to serum IgE concentrations
Source: International Congress 2015 – The immunology of allergic airway disease
Year: 2015


Antibody response after varicella vaccination similar in children treated with budesonide inhalation suspension (BIS) or nonsteroidal conventional asthma therapy (NSCAT)
Source: Eur Respir J 2006; 28: Suppl. 50, 711s
Year: 2006

The association between clinical features of asthma and impact of one-year sublingual immunotherapy on immunological system of atopic children
Source: Annual Congress 2013 –Treatment of asthma
Year: 2013

Do higher quantitative interferon gamma release assay or tuberculin skin test results help to predict incident tuberculosis? Data from the UK PREDICT study
Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection I
Year: 2019



Omalizumab (Xolair®) reduces exacerbations in adolescents more than in adults with allergic (IgE-mediated) asthma: a subgroup analysis of pooled clinical trials
Source: Annual Congress 2008 - Improving asthma and anti-allergic therapy
Year: 2008


Response to RD1 selected epitopes is associated to active tuberculosis. Results of a European multicentre hospital-based study: interim analysis of a European tuberculosis network (TBNET) study
Source: Eur Respir J 2007; 30: Suppl. 51, 752s
Year: 2007

Prospective study of concordance between tuberculin skin test (TST) and interferon-γ (IFNγ) assay in asymptomatic paediatric tuberculosis (TB) contacts
Source: Annual Congress 2009 - Diagnostic tools in paediatric respiratory infection
Year: 2009

Specific inhalation challenge tests for occupational asthma in Europe: a survey
Source: Eur Respir Rev 2014; 23:266-270
Year: 2014